. . . . . . . . . "dalfampridine extended release tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis ms this was demonstrated by an increase in walking speed see clinical studies 14 dalfampridine extended release tablets are a potassium channel blocker indicated to improve walking in adult patients with multiple sclerosis ms this was demonstrated by an increase in walking speed 1 14" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "FRtuLX277h55ItA0a1A30FYxBejXNJqodaz2IAUHOMdZ0nmsgJWiURrzjYdNz69LhpM1+5eyGYcww+thCA6e9parg7NYW+Wjwz84ilXGqie5UnevAqUbVUp9QytrVEAemntMKhvIi0HfHoCbNk7rYIuujMQjqulLYg9ROalSZbU=" . . "2021-06-14T08:22:21.307+02:00"^^ . . . . .